Mazur Leonard L
Insider CIK 1463414 · CTXR Executive Chairman, Director, 10% owner · CTOR Chief Executive Officer, Director · HILS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTOR CITIUS ONCOLOGY, INC. | A Award | 2025-09-19 | 2025-12-01 | 1,700,000 | — | $0 | 1,700,000 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award | 2025-09-19 | 2025-12-22 | 1,700,000 | — | $0 | 1,700,000 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award | 2025-09-19 | 2025-09-23 | 1,700,000 | — | $0 | 1,700,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2025-08-08 | 2025-09-23 | 125,490 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2025-08-08 | 2025-09-23 | 89,388 | — | $0 | 89,388 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2025-08-08 | 2025-09-23 | 89,388 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2025-08-08 | 2025-09-23 | 125,490 | — | $0 | 125,490 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award deriv | 2024-12-12 | 2024-12-16 | 800,000 | — | $0 | 800,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-11-07 | 2024-11-12 | 600,000 | — | $0 | 600,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-09-25 | 2024-09-27 | 2,234,700 | — | $0 | 2,234,700 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2024-09-25 | 2024-09-27 | 2,234,700 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-08-14 | 2024-09-27 | 3,137,255 | — | $0 | 3,137,255 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2024-08-14 | 2024-09-27 | 3,137,255 | — | $0 | 0 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award deriv | 2024-08-12 | 2024-08-14 | 1,233,333 | — | $0 | 1,233,333 | SEC↗ |
| CTOR CITIUS ONCOLOGY, INC. | A Award deriv | 2024-08-12 | 2024-08-30 | 3,700,000 | — | $0 | 3,700,000 | SEC↗ |
| THAR Tharimmune, Inc. | A Award deriv | 2024-08-09 | 2024-08-12 | 2,353 | — | $0 | 27,353 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2024-04-03 | 2024-04-05 | 1,165,048 | — | $0 | 1,165,048 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | D To issuer deriv | 2024-04-03 | 2024-04-05 | 1,165,048 | — | $0 | 0 | SEC↗ |
| THAR Tharimmune, Inc. | A Award deriv | 2023-11-07 | 2023-11-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2023-10-10 | 2023-10-12 | 550,000 | — | $0 | 550,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2022-10-04 | 2022-10-06 | 550,000 | — | $0 | 550,000 | SEC↗ |
| HILS Hillstream BioPharma Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HILS Hillstream BioPharma Inc. | C Conversion deriv | 2022-01-14 | 2022-01-18 | 0 | — | $0 | 0 | SEC↗ |
| HILS Hillstream BioPharma Inc. | P Buy | 2022-01-14 | 2022-01-18 | 25,000 | $4.00 | $100.0K | 123,733 | SEC↗ |
| HILS Hillstream BioPharma Inc. | C Conversion | 2022-01-14 | 2022-01-18 | 98,733 | $3.20 | $315.9K | 98,733 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2021-10-11 | 2021-10-13 | 650,000 | — | $0 | 650,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2021-07-22 | 2021-07-26 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2020-10-06 | 2020-10-09 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2019-10-08 | 2019-10-10 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy deriv | 2019-09-27 | 2019-09-27 | 2,234,700 | — | $0 | 2,234,700 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2019-09-27 | 2019-09-27 | 2,234,700 | $0.90 | $2.01M | 10,255,343 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy deriv | 2019-04-03 | 2019-04-05 | 1,165,048 | — | $0 | 1,615,048 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2019-04-03 | 2019-04-05 | 1,165,048 | $1.55 | $1.81M | 8,020,643 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2018-09-04 | 2018-09-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2018-08-13 | 2018-08-15 | 3,137,255 | — | $0 | 3,137,255 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2018-08-13 | 2018-08-15 | 3,137,255 | $1.28 | $4.02M | 6,855,595 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy deriv | 2018-03-29 | 2018-04-02 | 167,504 | — | $0 | 167,504 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2018-03-29 | 2018-04-02 | 167,504 | $2.99 | $500.8K | 3,718,340 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2017-12-19 | 2018-01-08 | 213,106 | $4.69 | $999.5K | 3,550,836 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2017-09-15 | 2017-09-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy deriv | 2017-08-24 | 2017-08-28 | 11,000 | $0.54 | $5.9K | 11,000 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2017-08-24 | 2017-08-28 | 11,000 | $2.68 | $29.5K | 3,337,730 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | C Conversion deriv | 2017-08-08 | 2017-08-10 | 1,547,067 | — | $0 | 0 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy deriv | 2017-08-08 | 2017-08-10 | 421,400 | $0.01 | $4.2K | 421,400 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | A Award deriv | 2017-08-08 | 2017-08-10 | 1,547,067 | — | $0 | 1,547,067 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | C Conversion | 2017-08-08 | 2017-08-10 | 1,547,067 | $3.09 | $4.78M | 3,326,730 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2017-08-08 | 2017-08-10 | 421,400 | $4.13 | $1.74M | 1,779,663 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 4,866,420 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 5,406,333 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 5,134,748 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 4,566,457 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 5,071,600 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 3,594,217 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 3,668,978 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 4,197,149 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other deriv | 2016-03-30 | 2016-04-12 | 0 | — | $0 | 4,244,707 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | P Buy | 2016-03-30 | 2016-04-12 | 5,000,000 | $0.60 | $3.00M | 5,457,143 | SEC↗ |
| CTXR Citius Pharmaceuticals, In | J Other | 2016-03-30 | 2016-04-12 | 15,116,746 | — | $0 | 20,116,746 | SEC↗ |